1.Conceptual analysis of ICU cognitive impairment: a literature review
Lu XU ; Zhixia JIANG ; Xingsong HE ; Fang CHEN ; Lifeng HE ; Yuan LI ; Linlin YOU ; Xin LU ; Xiaoling YANG
Chinese Journal of Practical Nursing 2023;39(8):631-636
Objective:To clarify the operational definition of ICU cognitive impairment, so as to provide a reference for accurate assessment of ICU cognitive impairment.Methods:ICU cognitive impairment was conceptually analyzed by the conceptual analysis framework in the Construction Strategy of Nursing Theory (Fifth Edition). The studies about cognitive function of critical illness patients in PubMed, Web of Science, Embase, China National Knowledge Internet, Wanfang, Chinese Biomedical Database, and VIP were searched. The search time limit was from the establishment of the database to August 2021. Literature screening and data extraction were performed independently by two researchers.Results:A total of 5 754 articles were obtained, and 48 articles were finally included. Obtained 20 concepts and 9 commonly used assessment tools related to ICU cognitive impairment. Identifying the defining attributes, conceptual causes, and outcomes of ICU cognitive impairment.Conclusions:The operational definition of ICU cognitive impairment is determined, which is conducive to a comprehensive and intuitive understanding of the concept of cognitive impairment in ICU and accurate evaluation of cognitive impairment in ICU.
2.Effects and Mechanism of Jidesheng Anti-venom Tablet on Local Wound Inflammation and Systemic Inflammatory Response of Snake Bite Patients
Jie HU ; Chaojin YANG ; Xingsong HE ; Zheng MING ; Zhihui XIE
China Pharmacy 2021;32(17):2102-2107
OBJECTIVE:To investigate the effects and mechanism of Jidesh eng anti-venom tablet on local wound inflammation and systemic inflammatory response of snake bite patients. METHODS :Totally 64 patients with snake bite admitted to our hospital during Jun. 2018-Jun. 2020 were randomly divided into control group and observation group ,with 32 cases in each group. Both groups received routine treatment ,such as debridement ,drainage,flushing,sealing,anti-venom,anti-infection,anti-fibrinolysis and anti-shock. Observation group was additionally given Jidesheng anti-venom tablet for internal and external use ,for consecutive 7 d. Related indexes of systemic inflammatory response ,local wound condition ,hospital stay ,laboratory indexes of important organs,coagulation function index ,wound inflammatory cell counts ,serum levels of inflammatory cytokines and chemokine ,the occurrence of ADR were compared between 2 groups. RESULTS :After treatment ,most of related indexes of systemic inflammatory response (RR,HR and WBC ),local wound condition (local pain disappearance time ,wound detumescence time ), hospital stay ,laboratory indexes of important organs (AST,ALT,Scr,BUN,CKB,CK-MB),coagulation function index (t-PA, PAI-1,TAT,SFMC),wound inflammatory cell (macrophages,neutrophils,lymphocytes)count,serum levels of inflammatory cytokines(TNF-α,IL-1,IL-6,hs-CRP,NF-κB)and chemokine (MCP-1,CXCL-8)in 2 groups were significantly better than before treatment (P<0.05);most indexes of observation group were significantly better than those of control group (P<0.05). No severe ADR was found in 2 groups. CONCLUSIONS :Jidesheng anti-venom tablet as auxiliary treatment can significantly reduce the local wound inflammation and systemic inflammatory response of snake bite patients ;the mechanism is probably related to reducing the levels of chemokine MCP- 1 and CXCL- 8 and inflammatory cytokines hs-CRP and NF-κB.
3.Clinical outcome of kidney transplantation from DBD donors complicated with acute kidney injury
Hongyu WANG ; Hong WANG ; Songying SHEN ; He ZHAO ; Xingsong QIN ; Wei QIN ; Xinling QIAN ; Huijun DONG ; Yunfeng ZHAO ; Yafang WANG ; Peiliang LI
Organ Transplantation 2024;15(4):622-629
Objective To evaluate the clinical outcome of kidney transplantation from donation after brain death (DBD) donors complicated with acute kidney injury (AKI). Methods Clinical data of 216 DBD donors were retrospectively analyzed, and they were divided into the AKI group (n=69) and control group (n=147) according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. Donors in the AKI group were further divided into the KDIGO stage 1 and stage 2-3 subgroups. One hundred and thirty-five recipients were assigned into the AKI group and 288 recipients in the control group. Postoperative recovery of renal function and clinical outcomes of the recipients were recorded. The risk factors of delayed graft function (DGF) were identified. Results The highest serum creatinine (Scr) level, Scr level before procurement, the highest blood sodium level and blood sodium level before procurement in the AKI group were higher than those in the control group. The application duration of vasopressors in the AKI group was longer than that in the control group. In the AKI group, the amount of fluid resuscitation within 48 h was higher, the HCO3− level at admission was lower, and the incidence of diabetes insipidus and hypotension was higher than those in the control group. The highest Scr level and the Scr level before procurement in KDIGO stage 2-3 donors were significantly higher than those in KDIGO stage 1 counterparts (all P<0.05). Compared with the control group, the incidence of DGF and acute rejection was higher, the proportion of continuous renal replacement therapy was higher, the Scr level within postoperative 90 d was higher, and the urine amount within postoperative 3 d was less than those of recipients in the AKI group. Compared with KDIGO stage 1 recipients, KDIGO stage 2-3 recipients had higher Scr levels at postoperative 3, 4, 5 and 15 d, and less urine amount at postoperative 2 d (all P<0.05). Univariate analysis showed that donor age, the highest Scr level, the highest blood sodium level and the amount of fluid resuscitation within 48 h were the risk factors for DGF in recipients after kidney transplantation. Multivariate analysis showed that donor age was the independent risk factor for DGF in recipients after kidney transplantation (all P<0.05). Conclusions For the application of DBD donors complicated with AKI, active organ maintenance should be performed to alleviate AKI. It exerts no effect upon graft function and survival rate at postoperative 6 months, which may achieve equivalent efficacy as non-AKI donors and may be used as a source of extended criteria donor kidneys.